Assessment of Systemic Oxidative Stress Modulation in Melasma Following Treatment with Yellow Light Laser 577 nm and Topical 0.3% 4N Butyl Resorcinol: A Comparative Prospective Study.

IF 1 4区 医学 Q4 DERMATOLOGY
Indian Journal of Dermatology Pub Date : 2025-03-01 Epub Date: 2025-02-27 DOI:10.4103/ijd.ijd_11_24
Neelam Khurana, Mohammad M Mehdi, Mohinder P S Sawhney, Sanjiv K Bansal
{"title":"Assessment of Systemic Oxidative Stress Modulation in Melasma Following Treatment with Yellow Light Laser 577 nm and Topical 0.3% 4N Butyl Resorcinol: A Comparative Prospective Study.","authors":"Neelam Khurana, Mohammad M Mehdi, Mohinder P S Sawhney, Sanjiv K Bansal","doi":"10.4103/ijd.ijd_11_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Melasma is an acquired hyperpigmentation disorder of the skin. Recent studies suggest that oxidative stress may contribute to the pathogenesis of melasma. Upregulated levels of circulatory antioxidants in blood serum and vascular endothelial growth factors in melasma lesions have been observed. The prospective study was conducted to compare the effect of the treatment of melasma with and without the use of a 577 nm vascular laser on levels of enzymatic antioxidants.</p><p><strong>Aims and objectives: </strong>To compare the modulation in the levels of enzymatic antioxidants in melasma patients treated with 577 nm yellow light laser in combination with topical depigmenting serum as compared to those using depigmenting serum alone.</p><p><strong>Materials and methods: </strong>Sixty patients with melasma of both sexes were randomly divided into groups of 30 each. Group A patients were treated with yellow light laser 577 nm (wavelength) once every 4 weeks for 4 sittings and topical depigmenting serum (4n butyl resorcinol) daily for 24 weeks. Group B patients were treated only with topical depigmenting serum. Levels of total antioxidant capacity (TAC), superoxide dismutase (SOD), inducible nitric oxide synthase (iNOS), glutathione peroxidase (GPx) and malondialdehydes (MDA) were estimated at 0 and 24 weeks.</p><p><strong>Results: </strong>Mean difference in lowering of the antioxidant levels in Group A and B was SOD1 (0.73 versus 0.12), GPX1, (0.62 versus 0.30), iNOS (1.56 versus 0.52), MDA, (0.73 versus 0.38), TAC (2.24 versus 1.28). A significantly higher mean of difference was observed in patients treated with combination therapy.</p><p><strong>Conclusion: </strong>Significantly higher reduction of enzymatic antioxidants with 577 nm yellow light laser in combination with 4 N-butyl resorcinol as compared to topical depigmenting agent alone recommends that combination therapy in melasma may target different aspects of a condition to enhance overall effectiveness.</p>","PeriodicalId":13401,"journal":{"name":"Indian Journal of Dermatology","volume":"70 2","pages":"57-62"},"PeriodicalIF":1.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11952710/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/ijd.ijd_11_24","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/27 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Melasma is an acquired hyperpigmentation disorder of the skin. Recent studies suggest that oxidative stress may contribute to the pathogenesis of melasma. Upregulated levels of circulatory antioxidants in blood serum and vascular endothelial growth factors in melasma lesions have been observed. The prospective study was conducted to compare the effect of the treatment of melasma with and without the use of a 577 nm vascular laser on levels of enzymatic antioxidants.

Aims and objectives: To compare the modulation in the levels of enzymatic antioxidants in melasma patients treated with 577 nm yellow light laser in combination with topical depigmenting serum as compared to those using depigmenting serum alone.

Materials and methods: Sixty patients with melasma of both sexes were randomly divided into groups of 30 each. Group A patients were treated with yellow light laser 577 nm (wavelength) once every 4 weeks for 4 sittings and topical depigmenting serum (4n butyl resorcinol) daily for 24 weeks. Group B patients were treated only with topical depigmenting serum. Levels of total antioxidant capacity (TAC), superoxide dismutase (SOD), inducible nitric oxide synthase (iNOS), glutathione peroxidase (GPx) and malondialdehydes (MDA) were estimated at 0 and 24 weeks.

Results: Mean difference in lowering of the antioxidant levels in Group A and B was SOD1 (0.73 versus 0.12), GPX1, (0.62 versus 0.30), iNOS (1.56 versus 0.52), MDA, (0.73 versus 0.38), TAC (2.24 versus 1.28). A significantly higher mean of difference was observed in patients treated with combination therapy.

Conclusion: Significantly higher reduction of enzymatic antioxidants with 577 nm yellow light laser in combination with 4 N-butyl resorcinol as compared to topical depigmenting agent alone recommends that combination therapy in melasma may target different aspects of a condition to enhance overall effectiveness.

黄光激光577 nm和外用0.3% 4N间苯二酚治疗黄褐斑后系统性氧化应激调节的比较前瞻性研究。
背景:黄褐斑是一种获得性皮肤色素沉着症。最近的研究表明,氧化应激可能与黄褐斑的发病机制有关。已观察到黄褐斑病变中血清循环抗氧化剂和血管内皮生长因子水平上调。这项前瞻性研究是为了比较使用和不使用577nm血管激光治疗黄褐斑对酶抗氧化剂水平的影响。目的和目的:比较577 nm黄光激光联合局部脱色血清治疗的黄褐斑患者与单独使用脱色血清治疗的黄褐斑患者酶促抗氧化剂水平的调节。材料与方法:将60例男女黄褐斑患者随机分为两组,每组30例。A组患者给予577 nm(波长)黄光激光治疗,每4周1次,连用4次,每日外用间苯二酚脱色血清,连用24周。B组患者只用局部脱色血清治疗。在0和24周时测定总抗氧化能力(TAC)、超氧化物歧化酶(SOD)、诱导型一氧化氮合酶(iNOS)、谷胱甘肽过氧化物酶(GPx)和丙二醛(MDA)水平。结果:A组和B组抗氧化剂水平降低的平均差异为SOD1(0.73比0.12),GPX1(0.62比0.30),iNOS(1.56比0.52),MDA(0.73比0.38),TAC(2.24比1.28)。在联合治疗的患者中观察到明显更高的平均差异。结论:与单独使用局部脱脂剂相比,577 nm黄光激光联合4正丁基间苯二酚对酶促抗氧化剂的降低明显更高,这表明黄褐斑联合治疗可能针对不同方面的疾病,以提高整体疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Indian Journal of Dermatology
Indian Journal of Dermatology Medicine-Dermatology
CiteScore
1.80
自引率
0.00%
发文量
217
审稿时长
47 weeks
期刊介绍: The journal publishes information related to skin-pathology and different modes of therapeutics, including dermatosurgery and cosmetic dermatology. Likewise, it carries articles on leprosy, STI and HIV/AIDS. The editorial board encourages the authors to publish articles addressing emerging techniques and developments in the subject specialty, in the form of Original investigations, Narrative and Systematic Reviews as well as Case Reports. The journal aims at publishing Editorials and Commentaries from eminent personalities on a regular basis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信